Comorbidities and disease severity as risk factors for Carbapenem-Resistant klebsiella pneumoniae colonization: Report of an experience in an internal medicine unit

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Nouvenne, Antonio ^a,b   Ticinesi, Andrea ^a,b   Lauretani, Fulvio ^a   Maggio, Marcello ^b   Lippi, Giuseppe ^a   Guida, Loredana ^a   Morelli, Ilaria ^a   Ridolo, Erminia ^a,b   Borghi, Loris ^a,b   Meschi, Tiziana ^a,b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUMULATIVE ILLNESS RATING SCALE; DISEASE SEVERITY; FEMALE; FRAIL ELDERLY; GERIATRIC HOSPITAL; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERNAL MEDICINE; ISOLATION PROCEDURE; ITALY; KIDNEY DISEASE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; RATING SCALE; RESPIRATORY TRACT DISEASE; RISK FACTOR; KLEBSIELLA INFECTIONS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

KLEBSIELLA PNEUMONIAE;

AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84908047018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110001     Document Type: Article

References (34)

1. Chen LF, Anderson DJ, Paterson DL (2012) Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist 5: 133-141.
2. Nordmann P, Poirel L (2002) Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 8: 321-331.
3. Cornaglia G, Giamarellou H, Rossolini GM (2011) Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 11: 381-393.
4. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, et al. (2001) Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbape-nem- resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45: 1151-1161.
5. Lomaestro BM, Tobin EH, Shang W, Gootz T (2006) The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis 43: e26-e28.
6. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, et al. (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13: 785-796.
7. Giani T, D′Andrea MM, Pecile P, Borgianni L, Nicoletti P, et al. (2009) Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC- 3 carbapenemase. J Clin Microbiol 47: 3793-3794.
8. Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9: 228-236.
9. Gaibani P, Ambretti S, Berlingeri A, Gelsomino F, Bielli A, et al. (2011) Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March-30 September 2010. Euro Surveill 12: pii 19800.
10. Giani T, Pini B, Arena F, Conte V, Bracco S, et al. (2013) Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 18: pii 20489.
11. Gagliotti C, Ciccarese V, Sarti M, Giordani S, Barozzi A, et al. (2013) Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting. J Hosp Infect 83: 330-332.
12. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, et al. (2012) Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18: 432-438.
13. Gasink LB, Edelstein PH, Lautenbach E, Synnestevedt M, Fishman NO (2009) Risk factors and clinical impact of Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae. Infect Control Hosp Epidemiol 30: 1180-1185.
14. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, et al. (2012) Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67: 2976-2981.
15. Armand-Lefe'vre L, Angebault C, Barbier F, Hamelet E, Defrance G, et al. (2013) Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57: 1488-1495.
16. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, et al. (2010) Bloodstream infections caused by metallo-β-lactamase/ Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31: 1250-1256.
17. Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, et al. (2011) Predictors of mortality in patients with bloodstream infections caused by KPCproducing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17: 1798-1803.
18. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, et al. (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55: 943-950.
19. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, et al. (2011) What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37: 415-419.
20. Hirsch EB, Guo B, Chang KT, Cao H, Ledesma KR, et al. (2013) Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. J Infect Dis 207: 786-793.
21. Daikos GL, Markogiannakis A (2011) Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect 17: 1135-1141.
22. nd, 2013. Italian language.
23. Jochimsen EM, Fish L, Manning K, Young S, Singer DA, et al. (1999) Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 20: 106-109.
24. Chitnis AS, Caruthers PS, Rao AK, Lamb J, Lurvey R, et al. (2012) Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 33: 984-992.
25. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, et al. (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41: 237-248.
26. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, et al. (2011) Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 49: 3986-3989.
27. Giuffre' M, Bonura C, Geraci DM, Saporito L, Catalano R, et al. (2013) Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect 85: 233-236.
28. Aschbacher R, Giani T, Corda D, Conte V, Arena F, et al. (2013) Carbapenemase-producing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): incresing diversity in a low-endemicity setting. Diagn Microbiol Infect Dis 77: 354-356.
29. Spysa V, Psichogiou M, Bouzala GA, Hadjihannas L, Hatzakis A, et al. (2012) Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit. PLoS One 7: e41068.
30. Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, et al. (2012) Imported Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination. J Clin Microbiol 50: 2618-2623.
31. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, et al. (2010) Successful control of an outbreak of Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 31: 341-347.
32. Munoz-Price LS, De La Cuesta C, Adams S, Wyckoff M, Cleary T, et al. (2010) Successful eradication of a monoclonal strain of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 31: 1074-1077.
33. Anderson DJ, Richet H, Chen LF, Spelman DW, Hung YJ, et al. (2008) Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Infect Dis 197: 752-756.
34. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM (2010) Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc 85: 139-144.